Reversible Hyperinsulinemic Hypoglycemia after Gastric Bypass: A Consequence of Altered Nutrient Delivery
Open Access
- 1 April 2010
- journal article
- other
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 95 (4), 1851-1855
- https://doi.org/10.1210/jc.2009-1628
Abstract
Context: Severe hypoglycemia after Roux-en-Y gastric bypass surgery (RYGB) is an increasingly recognized condition, characterized by neuroglycopenia and inappropriately elevated insulin concentrations that occur primarily in the postprandial state. Both pathophysiology and treatment of this disorder remain elusive, but it has been postulated that hyperplasia and/or hypertrophy of β-cells due to morbid obesity and/or postsurgical nesidioblastosis may contribute. Objective: The objective of this study was to elucidate the pathophysiology of this condition; specifically, we hypothesized that metabolic abnormalities were a function of altered nutrient transit through the gastrointestinal tract rather than anatomical changes to pancreatic β-cells that would lead to consistently high insulin secretion irrespective of nutrient transit route. Design/Setting/Subject/Outcome Measures: We describe a unique case wherein gastrostomy tube (GT) insertion into the remnant stomach reversed neuroglycopenic symptoms. This subject was admitted to a university hospital research center for standardized measurement of glucose, insulin, and incretin hormones including glucagon-like peptide-1, gastric-inhibitory peptide, and glucagon. Results: Standardized liquid meal administration via GT vs. oral route demonstrated complete reversal of severe metabolic abnormalities that included hypersecretion of insulin and GLP-1. Conclusion: Post-RYGB hyperinsulinemia and hypoglycemia result entirely from altered nutrient delivery rather than generalized hyperfunction of β-cells due to presurgical hypertrophy/hyperfunction or postsurgical nesidioblastosis. These findings support the use of GT for treatment of severe cases and have implications for surgical manipulations that may reverse/prevent this condition.Keywords
This publication has 23 references indexed in Scilit:
- Plasma Glucose and Insulin Regulation Is Abnormal Following Gastric Bypass Surgery with or Without NeuroglycopeniaObesity Surgery, 2009
- Gastrointestinal surgery as treatment for type 2 diabetesCurrent Opinion in Endocrinology, Diabetes and Obesity, 2008
- Hyperinsulinemic hypoglycemia following gastric bypass surgery for obesityCurrent Opinion in Endocrinology, Diabetes and Obesity, 2006
- Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satietyBritish Journal of Surgery, 2006
- Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasiaDiabetologia, 2005
- Hyperinsulinemic Hypoglycemia with Nesidioblastosis after Gastric-Bypass SurgeryNew England Journal of Medicine, 2005
- Bariatric SurgeryJama-Journal Of The American Medical Association, 2004
- Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell ApoptosisPublished by Elsevier BV ,2003
- Glucagon-Like Peptide-1 Promotes Islet Cell Growth and Inhibits Apoptosis in Zucker Diabetic RatsEndocrinology, 2002
- Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.Diabetes, 1999